YONGHE MED.GR.DL-0000025 (L97) — Defensive Interval Ratio

Latest as of December 2025: 40 days

YONGHE MED.GR.DL-0000025 (L97) has a Defensive Interval Ratio of 40 days as of December 2025. Defensive assets of €59.99 Million (cash €-, short-term investments €50.18 Million, receivables €9.81 Million) cover 40 days of daily cash needs of €1.50 Million/day. Check tangible equity quality of YONGHE MED.GR.DL-0000025 to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

40 days
Days of operational coverage

Defensive Assets

€59.99 Million
Cash + ST Investments + Receivables

Daily Cash Need

€1.50 Million
Current Liabilities ÷ 365

Current Liabilities

€549.30 Million
EUR

YONGHE MED.GR.DL-0000025 Defensive Interval Ratio (2021–2025)

This chart shows how YONGHE MED.GR.DL-0000025's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 40 days, meaning defensive assets of €59.99 Million can fund 40 days of operations without new revenue. Also explore YONGHE MED.GR.DL-0000025 annual equity growth to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for YONGHE MED.GR.DL-0000025 (2021–2025)

The table below presents the year-by-year Defensive Interval Ratio for YONGHE MED.GR.DL-0000025 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see YONGHE MED.GR.DL-0000025 (L97) market capitalisation.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2025 40 days €59.99 Million €1.50 Million/day €- €50.18 Million ▲ +37 days
2024 3 days €4.63 Million €1.50 Million/day €- €- ▼ -2 days
2023 5 days €10.27 Million €1.98 Million/day €- €- ▼ -302 days
2022 308 days €420.00 Million €1.37 Million/day €- €412.94 Million ▲ +301 days
2021 7 days €13.35 Million €2.02 Million/day €- €-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)